Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
+17.95%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$10.2B
AUM Growth
+$1.96B
(+24%)
Cap. Flow
+$684M
Cap. Flow
% of AUM
6.68%
Top 10 Holdings %
Top 10 Hldgs %
43.19%
Holding
1,081
New
132
Increased
418
Reduced
456
Closed
74
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$295M |
| 2 |
VanEck Gold Miners ETF
GDX
|
$118M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$97.9M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
$55.8M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
$27.6M |
Top Sells
| 1 |
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
$107M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
$32.9M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
$17.7M |
| 4 |
Lockheed Martin
LMT
|
$13.5M |
| 5 |
Apple
AAPL
|
$10.9M |
Sector Composition
| 1 | Technology | 26.66% |
| 2 | Financials | 16.65% |
| 3 | Industrials | 3.24% |
| 4 | Energy | 3.1% |
| 5 | Consumer Discretionary | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
The RealReal
REAL
$999M
| $309K | ﹤0.01% |
+15,796
| New | +$309K |
|
802
Quest Diagnostics
DGX
$20.5B
| $307K | ﹤0.01% |
2,579
-238
| -8% | -$28.3K |
|
803
Vanda Pharmaceuticals
VNDA
$272M
| $307K | ﹤0.01% |
23,330
-42,064
| -64% | -$554K |
|
|
CONE
804
DELISTED
CyrusOne Inc Common Stock
CONE
| $307K | ﹤0.01% |
4,195
-4,978
| -54% | -$364K |
|
805
CarMax
KMX
$9.11B
| $306K | ﹤0.01% |
3,241
+28
| +0.9% | +$2.64K |
|
806
Pediatrix Medical
MD
$1.49B
| $306K | ﹤0.01% |
+12,463
| New | +$306K |
|
807
Iron Mountain
IRM
$27.2B
| $305K | ﹤0.01% |
10,350
-154
| -1% | -$4.54K |
|
808
American Homes 4 Rent
AMH
$12.9B
| $304K | ﹤0.01% |
10,138
+838
| +9% | +$25.1K |
|
809
Atlantic Union Bankshares
AUB
$5.09B
| $302K | ﹤0.01% |
9,171
-6,321
| -41% | -$208K |
|
810
Triumph Financial, Inc.
TFIN
$1.52B
| $299K | ﹤0.01% |
+6,167
| New | +$299K |
|
811
Travere Therapeutics
TVTX
$1.93B
| $299K | ﹤0.01% |
10,969
-29,575
| -73% | -$806K |
|
812
Kiniksa Pharmaceuticals
KNSA
$2.65B
| $296K | ﹤0.01% |
+16,767
| New | +$296K |
|
813
Omega Healthcare
OHI
$12.7B
| $296K | ﹤0.01% |
8,152
+347
| +4% | +$12.6K |
|
|
FMTX
814
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $295K | ﹤0.01% |
+8,463
| New | +$295K |
|
|
ANAT
815
DELISTED
American National Group, Inc. Common Stock
ANAT
| $295K | ﹤0.01% |
+3,065
| New | +$295K |
|
816
Cooper Companies
COO
$13.5B
| $294K | ﹤0.01% |
3,232
-632
| -16% | -$57.5K |
|
817
National Presto Industries
NPK
$782M
| $294K | ﹤0.01% |
3,322
+147
| +5% | +$13K |
|
818
Waters Corp
WAT
$18.2B
| $294K | ﹤0.01% |
1,188
-112
| -9% | -$27.7K |
|
|
STOR
819
DELISTED
STORE Capital Corporation
STOR
| $294K | ﹤0.01% |
8,647
+657
| +8% | +$22.3K |
|
|
VER
820
DELISTED
VEREIT, Inc.
VER
| $293K | ﹤0.01% |
7,741
+324
| +4% | +$12.3K |
|
821
Alliant Energy
LNT
$16.6B
| $292K | ﹤0.01% |
5,666
+1,468
| +35% | +$75.7K |
|
822
Steris
STE
$24.2B
| $292K | ﹤0.01% |
1,542
-129
| -8% | -$24.4K |
|
823
Vroom, Inc. Common Stock
VRM
$140M
| $292K | ﹤0.01% |
+89
| New | +$292K |
|
824
Rhythm Pharmaceuticals
RYTM
$6.78B
| $291K | ﹤0.01% |
9,779
-902
| -8% | -$26.8K |
|
825
Guess, Inc.
GES
$878M
| $290K | ﹤0.01% |
12,809
-10,531
| -45% | -$238K |
|